Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/27/2023 | Century Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 44k | $3.19 | $140.4k | | 06/27/2023 |
06/15/2022 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 15k | $7.66 | $114.9k | | 06/15/2022 |
06/09/2022 | Century Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 19.9k | $8.56 | $170.1k | | 06/09/2022 |
05/16/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Stock Option (Right to Buy) | 427.2k | $24.41 | $10.4M | | 05/16/2022 |
05/16/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Stock Option (Right to Buy) | 1.7M | $24.41 | $41.7M | | 05/16/2022 |
01/03/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Exercise | Stock Option (Right to Buy) | 1000 | $47.80 | $47.8k | | 01/03/2022 |
01/03/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 1000 | $83.74 | $83.7k | | 01/03/2022 |
12/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Exercise | Stock Option (Right to Buy) | 1000 | $47.80 | $47.8k | | 12/01/2021 |
12/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 1000 | $81.84 | $81.8k | | 12/01/2021 |
11/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Exercise | Stock Option (Right to Buy) | 1000 | $47.80 | $47.8k | | 11/01/2021 |
11/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 1000 | $80.46 | $80.5k | | 11/01/2021 |
10/25/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Exercise | Stock Option (Right to Buy) | 1000 | $47.80 | $47.8k | | 10/25/2021 |
10/25/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 1000 | $77.59 | $77.6k | | 10/25/2021 |
06/23/2021 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 47.1k | $19.00 | $895.5k | | 04/12/2021 |
06/17/2021 | Century Therapeutics, Inc. | | Grant | Option (right to buy) | 19.9k | $20.00 | $397.4k | | 06/17/2021 |
06/04/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Stock Option (Right to Buy) | 15k | $52.25 | $783.8k | | 06/04/2021 |
06/04/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Common Stock | 5k | $0.00 | $0 | | 06/04/2021 |
04/12/2021 | Monte Rosa Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 7.1k | $0.00 | $0 | | 04/12/2021 |
07/01/2020 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Stock Option (Right to Buy) | 42k | $47.80 | $2M | | 07/01/2020 |